2016
DOI: 10.21037/phe.2016.11.06
|View full text |Cite
|
Sign up to set email alerts
|

Survey of patients’ CT radiation dose in Jiangsu Province

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…And we compared the DRLs (Q3) of CTDI vol and DLP in our study with those in other researches or guidelines published in previous, including DRLs from the United States of America (13), UK (15), Japan (18), and China's Jilin (19) and Jiangsu (20) Province. The results are shown in Figures 1 and 2 [Zhou et al's (20) study did not provide DRLs of CTDI vol .…”
Section: Comparison With Other Drlsmentioning
confidence: 99%
See 1 more Smart Citation
“…And we compared the DRLs (Q3) of CTDI vol and DLP in our study with those in other researches or guidelines published in previous, including DRLs from the United States of America (13), UK (15), Japan (18), and China's Jilin (19) and Jiangsu (20) Province. The results are shown in Figures 1 and 2 [Zhou et al's (20) study did not provide DRLs of CTDI vol .…”
Section: Comparison With Other Drlsmentioning
confidence: 99%
“…In China, although the national standard of DRLs for adults in CT scans has been issued by the National Health Commission (27), there are still few studies on dose data of a large sample of patients or multicenter and cross-regional studies. Zhou et al (20) and Zhou et al (19) investigated radiation dose data from CT scans in Jiangsu and Jilin provinces of China to help establish their local DRLs, but these studies did not collect data of singlephase and multi-phase scans separately. Multiphase scans, including angiography and contrast-enhanced scans, often have higher radiation doses than plain scans because they require separate scans before and after contrast injections.…”
Section: Comparison With Other Drlsmentioning
confidence: 99%
“…The k-factor is defined as the proportionality constant between the effective dose and the DLP. In the clinical setting, the DLP is understood to be the product of the CTDIvol and the scan length: where the k is k-factor (mSv mGy-1 cm-1), E is effective dose (mSv), DLP is dose-length product (mGy cm), CTDIvol is in mGy and l is the scan length (cm) for different scan types (Zhou et al, 2017). The k-factors used to date were initially developed by Shrimpton et al using computational phantoms (Shrimpton, PC, Hillier MC, 2014).…”
Section: Introductionmentioning
confidence: 99%